Vaccine Information Experts

Med Communications is extremely strong in its vaccine support portfolio. Med Communications supports 60% of the United States’ influenza manufacturers, and one-third of total influenza products on the market. During the 2009 H1N1 pandemic, Med Communications managed an increase of call volume greater than 1000% and our service levels never dipped under 90% of key performance indicators (KPIs). We are extremely proficient in seasonal products and also support respiratory syncytial virus (RSV), travel vaccines, and childhood immunizations.